Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

Study Description: The overarching goal of this research protocol is to acquire eye-tracking, cognitive, and disease-severity metrics in multiple sclerosis (MS) patients to further build up a database of MS patients and train a machine learning classifying algorithms to identify which eye-tracking metrics-or combination thereof-can serve as reliable markers of MS disease severity and cognitive status.

Detailed Description: This study will use a single group design in a cohort of MS patients. Eligible patients with MS will be selected and categorized based on their Expanded Disability Status Scale (EDSS) score. Patients eye movements will be captured using the patented eye-tracking technology at one single time point. In addition to the eye-tracking tests, patient phenotypes will be further detailed via brief functional and cognitive assessments using the EDSS, Brief International Cognitive Assessment for MS (BICAMS) and Multiple Sclerosis Functional Composite (MSFC). All patients will be required to participate in a single session.

Study Design 

Study Type: Observational [Patient Registry]
Estimated Enrollment: 120 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 2 Years
Official Title: Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis
Study Start Date: August 16, 2023


Learn more >